Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer.
Pichler R, Stäblein J, Mari A, Afferi L, D'Andrea D, Marcq G, Del Giudice F, Soria F, Caño-Velasco J, Subiela JD, Gallioli A, Tully KH, Mori K, Herms A, Pradere B, Moschini M, Mertens LS, Thurnher M; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Pichler R, et al. Among authors: d andrea d. J Clin Med. 2024 Mar 31;13(7):2031. doi: 10.3390/jcm13072031. J Clin Med. 2024. PMID: 38610796 Free PMC article.
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
von Deimling M, Mertens LS, Furrer M, Li R, Tendijck GAH, Taylor J, Crocetto F, Maas M, Mari A, Pichler R, Moschini M, Tully KH, D'Andrea D, Laukhtina E, Del Giudice F, Marcq G, Velev M, Gallioli A, Albisinni S, Mori K, Khanna A, Rink M, Fisch M, Minervini A, Black PC, Lotan Y, Spiess PE, Kiss B, Shariat SF, Pradere B; CLIPOLY Study Group Collaborators. von Deimling M, et al. Among authors: d andrea d. BJU Int. 2024 Mar 12. doi: 10.1111/bju.16319. Online ahead of print. BJU Int. 2024. PMID: 38470089 Free article.
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics.
Subiela JD, Krajewski W, González-Padilla DA, Laszkiewicz J, Taborda J, Aumatell J, Sanchez Encinas M, Basile G, Moschini M, Caño-Velasco J, Lopez Perez E, Del Olmo Durán P, Gallioli A, Tukiendorf A, D'Andrea D, Yuen-Chun Teoh J, Serna Céspedes A, Pichler R, Afferi L, Del Giudice F, Gomez Rivas J, Albisinni S, Soria F, Ploussard G, Mertens LS, Rajwa P, Laukhtina E, Pradere B, Tully K, Guerrero-Ramos F, Rodríguez-Faba Ó, Alvarez-Maestro M, Dominguez-Escrig JL, Szydełko T, Gomez Dos Santos V, Jiménez Cidre MÁ, Burgos Revilla FJ; European Association of Urology-Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group. Subiela JD, et al. Among authors: d andrea d. Eur Urol Oncol. 2024 Feb 13:S2588-9311(24)00043-9. doi: 10.1016/j.euo.2024.01.017. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38355375
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.
Di Modugno F, Di Carlo A, Spada S, Palermo B, D'Ambrosio L, D'Andrea D, Morello G, Belmonte B, Sperduti I, Balzano V, Gallo E, Melchionna R, Panetta M, Campo G, De Nicola F, Goeman F, Antoniani B, Carpano S, Frigè G, Warren S, Gallina F, Lambrechts D, Xiong J, Vincent BG, Wheeler N, Bortone DS, Cappuzzo F, Facciolo F, Tripodo C, Visca P, Nisticò P. Di Modugno F, et al. Among authors: d andrea d. EBioMedicine. 2024 Mar;101:105003. doi: 10.1016/j.ebiom.2024.105003. Epub 2024 Feb 9. EBioMedicine. 2024. PMID: 38340557 Free PMC article.
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
Fletcher SA, Pallauf M, Watts EK, Lombardo KA, Campbell JA, Rezaee ME, Rouprêt M, Boorjian SA, Potretzke AM, Roshandel MR, Ploussard G, Djaladat H, Ghoreifi A, Mari A, Campi R, Khene ZE, Raman JD, Kikuchi E, Rink M, Abdollah F, Boormans JL, Fujita K, D'Andrea D, Soria F, Breda A, Hoffman-Censits J, McConkey DJ, Shariat SF, Pradere B, Singla N. Fletcher SA, et al. Among authors: d andrea d. Eur Urol Oncol. 2024 Jan 22:S2588-9311(24)00035-X. doi: 10.1016/j.euo.2024.01.010. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38262800
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Prattichizzo F, Sardu C, Rambaldi PF, Fumagalli C, Marfella LV, La Grotta R, Frigé C, Pellegrini V, D'Andrea D, Cesaro A, Calabrò P, Pizzi C, Antonicelli R, Ceriello A, Mauro C, Paolisso G. Marfella R, et al. Among authors: d andrea d. Cardiovasc Diabetol. 2024 Jan 6;23(1):10. doi: 10.1186/s12933-023-02118-6. Cardiovasc Diabetol. 2024. PMID: 38184582 Free PMC article.
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancer.
Rajwa P, Quhal F, D'Andrea D, Korn S, Petrov P, Yanagisawa T, Kawada T, Motlagh RS, Mostafaei H, Laukhtina E, Aydh A, König F, Pallauf M, Pradere B, Nyirády P, Abufaraj M, Marra G, Gandaglia G, Briganti A, Karakiewicz P, Ye DW, Haydter M, Chlosta P, Comperat E, Enikeev D, Shariat SF. Rajwa P, et al. Among authors: d andrea d. Arab J Urol. 2023 Apr 3;21(4):241-247. doi: 10.1080/2090598X.2023.2196911. eCollection 2023. Arab J Urol. 2023. PMID: 38178943 Free PMC article.
Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of Immunotherapy.
Hassler MR, Moedlagl V, Hindinger H, Krauter J, Klager S, Resch I, Huebner N, Yurdakul O, Ofner H, Korn SM, D'Andrea D, Gust K, Shariat SF. Hassler MR, et al. Among authors: d andrea d. Eur Urol Focus. 2023 Dec 30:S2405-4569(23)00294-8. doi: 10.1016/j.euf.2023.12.005. Online ahead of print. Eur Urol Focus. 2023. PMID: 38161107 Free article.
306 results